Diabetes type 2 trial for people with heart risks
Part of Hormones & metabolism clinical trials.
This study compares different diabetes medicines to see which works best for people with type 2 diabetes who also have heart or blood vessel risks. It aims to find better treatment to protect your heart and kidneys.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 19 years or older.
- You have type 2 diabetes (not type 1).
- Your A1c (recent blood sugar average) is between 7.0% and 10.0% and you take 1–3 oral diabetes medicines.
- You have a history of heart disease, stroke, or related blood vessel conditions, OR you have at least two of these risk factors: smoking, high blood pressure, low good cholesterol, family history of early heart disease, or obesity.
- You do not have severe heart failure, have not been in the hospital for a heart attack/stroke in the last 3 months, and do not have active cancer or very poor kidney function.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at heart disease risk and how diabetes medications are used in people with type 2 diabetes. It may help doctors better manage your heart health.
This trial tests a combination of three diabetes medicines (henagliflozin proline, retagliptin, and metformin) for people newly diagnosed with type 2 diabetes. The goal is to see how well the combination controls blood sugar and to check its safety.
This study tests whether taking two separate blood pressure medications work as well as taking them combined in one pill for people with high blood pressure and type 2 diabetes. The goal is to find the best, safest way to treat both conditions together.
This study looks at the safety and effectiveness of adding a third oral diabetes medicine to your current two-drug combination. It is for adults with type 2 diabetes whose blood sugar is not well controlled on metformin plus one other pill.
This Phase 4 trial studies an approach to help prevent heart problems in adults with type 2 diabetes who are at higher heart risk. It may help reduce future cardiovascular events by testing medications for safety and benefit in this group.
This trial studies how diabetes medicines (GLP-1 and SGLT2, alone or together) affect the heart in people with type 2 diabetes who are at higher cardiovascular risk and have heart failure with preserved pumping function. It may help find safer or more effective ways to reduce heart problems.
Hear when a new Type 2 diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.